tiapridal 138,03mg/ml η 5mg/dr or.so.d
sanofi-synthelabo a.e. - tiapride - ΠΟΣΙΜΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 138,03mg/ml η 5mg/dr - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
adrenaline 1mg/ml solution for injection
martindale pharmaceuticals ltd (0000003314) bampton road, harold hill, romford, rm3 8ug - epinephrine - solution for injection - 1mg/ml - epinephrine (0000051434) 1mg - epinephrine
adrenaline (epinephrine) 0.01%w/v solution for injection
aurum pharmaceuticals ltd (0000003323) bampton road, harold hill, romford, essex , rm3 8ug - epinephrine bitartrate - solution for injection - 0.01%w/v - epinephrine bitartrate (0000051423) 0.01% w/v - epinephrine
dobutamine concentrate
hameln pharmaceuticals ltd - ΔΟΒΟΥΤΑΜΊΝΗ ΥΔΡΟΧΛΩΡΙΚΉ - solution for infusion, concentrate for - 12.5mg/ml - 0052663817 - dobutamine hydrochloride - 14 mg - dobutamine
ferrous fumarate 200mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - ferrous fumarate - film coated tablets - 200mg - ferrous fumarate (0000141015) 200mg - ferrous fumarate
ferrous fumarate
c a papaellinas ltd - ΣΙΔΗΡΟΎΧΑ fumarate - ΣΙΡΟΠΙ - 140mg/5ml - 0000141015 - ferrous fumarate - 140 mg - ferrous fumarate
foliron 100mg/0.35mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - folic acid hydrate; iron - film coated tablets - 100mg/0.35mg - folic acid hydrate (8000004821) 0,35mg; iron (0007439896) 100mg - iron in combination with folic acid
tiapridal 100mg tablets
sanofi-aventis cyprus ltd - tiapride hydrochloride - tablets - 100mg - 0051012330 - tiapride hydrochloride - 100 mg base - tiapride
tivel 1mg tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - rasagiline tartrate - tablets - 1mg - rasagiline tartrate (0136236527) 1,438mg - rasagiline
ontilyv
bial portela & companhia s.a. - opicapone - Νόσος του Πάρκινσον - Αντιπαρκινσονικά φάρμακα - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.